What is the current glycopyrronium market size?

The glycopyrronium market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the glycopyrronium market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the glycopyrronium market?

Increasing demand for anticholinergic medications drives the glycopyrronium market.

What challenges does the glycopyrronium market face?

Patent expirations and generic competition pose significant challenges.

Which regions lead the glycopyrronium market?

North America and Europe are the leading regions in the glycopyrronium market.

Who are the top companies in the glycopyrronium market?

Major pharmaceutical companies dominate the glycopyrronium market.

What future opportunities exist in the glycopyrronium market?

Emerging markets and new indications offer future opportunities.

How does technology impact the glycopyrronium market?

Advances in drug delivery systems impact the glycopyrronium market.

What is the regulatory landscape for the glycopyrronium market?

Stringent regulations govern the glycopyrronium market.

What is the future outlook for the glycopyrronium market?

The future outlook is positive with growing demand.

glycopyrronium Market Potential & Strategic Outlook 2033

glycopyrronium by Application (Hospital, Clinic), by Types (Injection, Oral Solution, Tablet, Capsule), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.9%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

glycopyrronium Market Overview

The glycopyrronium market refers to the global industry involved in the production and distribution of glycopyrronium, a medication used to reduce salivation, bronchial secretions, and other bodily fluids. As a key component in various medical treatments, the glycopyrronium market size is expected to experience significant growth, driven by its increasing demand in the healthcare sector. The growth outlook for the glycopyrronium market appears promising, with a steady market forecast anticipated over the forecast period. The industry expansion is expected to be influenced by factors such as rising healthcare expenditures, an aging population, and the growing prevalence of respiratory diseases. According to recent data, the current glycopyrronium market size is approximately $1.3 billion.

Loading chart…

The glycopyrronium market is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma. Key forces shaping the industry include technology shifts, such as the development of new inhalation devices, regulations, such as stringent safety and efficacy standards, and competitive intensity, with major players competing for market share. The largest region for the glycopyrronium market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising healthcare expenditures and an aging population.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.44 billion
Growth rate	CAGR of 8.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Accord Healthcare; AstraZeneca; Merz Pharmaceuticals; Carwin Pharma; Sunovion Pharmaceuticals; Shionogi Inc; Novartis AG; Proveca Limited; Martindale Pharma; Meitheal Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The glycopyrronium market is poised for significant growth, driven by various factors. Two key growth drivers are:

Growth Drivers2 items

Increasing prevalence of chronic obstructive pulmonary disease (COPD) and other respiratory disorders, which is expected to drive the demand for glycopyrronium market size and contribute to its growth forecast

Advancements in drug delivery technologies, such as inhalers and nebulizers, which are likely to enhance the efficacy and convenience of glycopyrronium administration, further boosting the glycopyrronium market

However, the glycopyrronium market also faces certain restraints. Two key restraints are:

Restraints2 items

Stringent regulatory requirements and intense competition in the pharmaceutical industry, which may hinder the growth of the glycopyrronium market size and impact its growth forecast

Potential side effects and contraindications associated with glycopyrronium, which may limit its adoption and affect the overall glycopyrronium market

The glycopyrronium market presents several opportunities for growth and expansion. Two key opportunities are:

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America, which offer significant potential for the glycopyrronium market due to their large and growing populations, increasing healthcare expenditures, and rising demand for respiratory therapies

Growing focus on personalized medicine and targeted therapies, which may lead to the development of novel glycopyrronium formulations and treatments, driving innovation and growth in the glycopyrronium market

Despite these opportunities, the glycopyrronium market also faces challenges. Two key challenges are:

Challenges2 items

Patent expirations and generic competition, which may erode the market share of branded glycopyrronium products and impact the overall glycopyrronium market size and growth forecast

Increasing pricing pressure and reimbursement constraints, which may affect the profitability of glycopyrronium manufacturers and influence the glycopyrronium market's growth trajectory

Market Segmentation

Loading chart…

The glycopyrronium market can be segmented based on application, which refers to the various uses of glycopyrronium in different medical treatments. This segmentation is crucial in understanding the glycopyrronium segmentation and its contribution to the overall market size. The application segment includes subtypes such as respiratory diseases, gastrointestinal disorders, and others. Each subtype has a significant impact on the market size, with respiratory diseases being the largest contributor.

Another way to segment the glycopyrronium market is by types, which refers to the different forms of glycopyrronium available in the market. This includes subtypes such as injectable, oral, and topical forms. The type segment is important in understanding the market taxonomy and how it affects the overall market size. The injectable form is the most commonly used, followed by oral and topical forms. Understanding the types of glycopyrronium is essential in analyzing the market trends and forecasts.

glycopyrronium Segmentation Breakdown8 items

Application

Hospital

Clinic

Types

Injection

Oral Solution

Tablet

Capsule

Regional Insights

Loading chart…

The glycopyrronium market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, driven by increasing adoption of glycopyrronium in respiratory care, government investments in healthcare infrastructure, and a large patient population with respiratory diseases. North America is the fastest-growing region, with a regional forecast indicating a significant increase in demand due to rising awareness of glycopyrronium benefits, expanding insurance coverage, and growing research in pharmaceuticals.

Key drivers for each region include: for North America, expanding healthcare services and increasing demand for respiratory treatments; for Europe, established healthcare systems and growing geriatric population; for Asia Pacific, rapidly developing economies and improving access to healthcare services; for Latin America, government initiatives to improve healthcare infrastructure and rising awareness of glycopyrronium uses; and for Middle East & Africa, increasing investments in pharmaceutical research and growing demand for specialized treatments.

Competitive Landscape

The glycopyrronium market is moderately consolidated, with a mix of global players and local companies competing for market share. Key competitive levers include pricing, distribution, and product innovation, as well as certifications and regulatory approvals. The glycopyrronium competitive landscape is driven by companies seeking to differentiate themselves through strategic partnerships, R&D investments, and localized product offerings.

Companies in the glycopyrronium market employ various strategies to gain a competitive edge, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies focus on technology, service models, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Accord Healthcare: regional expansion

AstraZeneca: innovation pipeline

Merz Pharmaceuticals: premium pricing

Carwin Pharma: local manufacturing

Sunovion Pharmaceuticals: OEM tie-ups

Shionogi Inc: vertical integration

Key glycopyrronium Companies10 items

Accord Healthcare

AstraZeneca

Merz Pharmaceuticals

Carwin Pharma

Sunovion Pharmaceuticals

Shionogi Inc

Novartis AG

Proveca Limited

Martindale Pharma

Meitheal Pharmaceuticals

Market Ecosystem

The glycopyrronium ecosystem encompasses a complex network of stakeholders, from upstream raw material suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value being created and captured at each stage. Technology providers and suppliers form the foundation of the ecosystem, providing essential components and expertise that are then integrated by manufacturers and system integrators. These intermediaries, in turn, supply their products and services to channels and end users, who ultimately drive demand for glycopyrronium.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce glycopyrronium formulations

Technology providers — develop manufacturing processes and equipment

System integrators / EPCs — integrate glycopyrronium into larger medical systems

Distributors / channel partners — supply glycopyrronium to healthcare providers

Regulators/standards bodies — oversee safety and efficacy standards

End users / buyers — prescribe and administer glycopyrronium

In the glycopyrronium ecosystem, control points are largely influenced by regulators and standards bodies, who dictate the approval and adoption of glycopyrronium-based products. Dependency risks, such as input constraints and approval timelines, can impact the stability of the ecosystem. Furthermore, switching costs and partnerships between manufacturers and suppliers can affect the interoperability of glycopyrronium products. A thorough value chain analysis of the glycopyrronium ecosystem is necessary to understand these dynamics and identify potential bottlenecks. As the glycopyrronium ecosystem differs by region, due to varying regulatory frameworks and market conditions, a nuanced understanding of these regional differences is crucial for stakeholders seeking to navigate this complex landscape.

Recent Industry Insights

The glycopyrronium industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been forged to enhance research and development in the glycopyrronium market, with a focus on improving treatment options for various medical conditions. Notable mergers and acquisitions have also taken place, leading to increased consolidation and competition in the industry.

Furthermore, there have been several product launches and technological advancements, expanding the range of glycopyrronium-based products available. Regulatory changes have also impacted the industry, with updated guidelines and standards influencing the manufacturing and distribution of glycopyrronium products. These developments are expected to shape the future of the glycopyrronium industry, with a growing emphasis on innovation and customer satisfaction driving glycopyrronium industry trends forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the glycopyrronium market. The market attractiveness is moderate, driven by increasing demand for anticholinergic medications. The competitive intensity is high, with several key players operating in the market. The long-term outlook for the glycopyrronium market outlook is positive, with opportunities for growth in emerging economies. However, the innovation landscape is relatively stagnant, with limited new product developments in recent years.

The demand-supply balance is currently stable, but may be disrupted by key risk factors such as regulatory changes and supply chain disruptions. To mitigate these risks, market players must focus on strategic partnerships, research and development, and supply chain optimization. Overall, the glycopyrronium market is expected to experience steady growth, driven by increasing demand for effective treatments for respiratory and gastrointestinal disorders.

12 items

1. Executive Summary

2. glycopyrronium Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global glycopyrronium Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global glycopyrronium Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global glycopyrronium Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global glycopyrronium Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global glycopyrronium Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global glycopyrronium Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global glycopyrronium Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global glycopyrronium Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global glycopyrronium Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global glycopyrronium Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global glycopyrronium Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global glycopyrronium Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global glycopyrronium Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global glycopyrronium Market Competition by Key Manufacturers

9.1. Global glycopyrronium Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global glycopyrronium: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Accord Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. AstraZeneca

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merz Pharmaceuticals

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Carwin Pharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sunovion Pharmaceuticals

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Shionogi Inc

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Novartis AG

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Proveca Limited

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Martindale Pharma

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Meitheal Pharmaceuticals

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global glycopyrronium Market

Figure 4: Global glycopyrronium Market: Drivers

Figure 5: Global glycopyrronium Market: Challenges

Figure 6: Global glycopyrronium Market: Trends

Figure 7: Global glycopyrronium Market: Opportunity

Figure 8: Global glycopyrronium Market: Restraint

Figure 9: Global glycopyrronium Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global glycopyrronium Market Value (USD Million) By Region

Figure 19: Global glycopyrronium Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global glycopyrronium Market Value (USD Million) By Region

Figure 27: Global glycopyrronium Market Share (%) By: Regions (2032)

Figure 28: Global glycopyrronium Market Volume (K) By Region

Figure 29: Global glycopyrronium Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global glycopyrronium Market Value (USD Million) By Region

Figure 37: Global glycopyrronium Market Share (%) By: Regions (2032)

Figure 38: Global glycopyrronium Market Volume (K) By Region

Figure 39: Global glycopyrronium Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global glycopyrronium Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global glycopyrronium Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global glycopyrronium Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global glycopyrronium Market Value (USD Million) By Region

Table 14: Global glycopyrronium Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global glycopyrronium Market Volume (K) By Region

Table 31: Global glycopyrronium Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global glycopyrronium Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global glycopyrronium Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global glycopyrronium Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Accord Healthcare Basic Information And Sales Area

Table 52: Accord Healthcare. Products Portfolio

Table 53: AstraZeneca Basic Information And Sales Area

Table 54: AstraZeneca. Products Portfolio

Table 55: Merz Pharmaceuticals Basic Information And Sales Area

Table 56: Merz Pharmaceuticals. Products Portfolio

Table 57: Carwin Pharma Basic Information And Sales Area

Table 58: Carwin Pharma. Products Portfolio

Table 59: Sunovion Pharmaceuticals Basic Information And Sales Area

Table 60: Sunovion Pharmaceuticals. Products Portfolio

Table 61: Shionogi Inc Basic Information And Sales Area

Table 62: Shionogi Inc. Products Portfolio

Table 63: Novartis AG Basic Information And Sales Area

Table 64: Novartis AG. Products Portfolio

Table 65: Proveca Limited Basic Information And Sales Area

Table 66: Proveca Limited. Products Portfolio

Table 67: Martindale Pharma Basic Information And Sales Area

Table 68: Martindale Pharma. Products Portfolio

Table 69: Meitheal Pharmaceuticals Basic Information And Sales Area

Table 70: Meitheal Pharmaceuticals. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global glycopyrronium Market Value (USD Million) By Region

Table 80: Global glycopyrronium Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global glycopyrronium Market Volume (K) By Region

Table 97: Global glycopyrronium Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

glycopyrronium Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.44 billion
Growth rate	CAGR of 8.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Accord Healthcare; AstraZeneca; Merz Pharmaceuticals; Carwin Pharma; Sunovion Pharmaceuticals; Shionogi Inc; Novartis AG; Proveca Limited; Martindale Pharma; Meitheal Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The glycopyrronium market is poised for significant growth, driven by various factors. Two key growth drivers are:

Growth Drivers2 items

However, the glycopyrronium market also faces certain restraints. Two key restraints are:

Restraints2 items

Stringent regulatory requirements and intense competition in the pharmaceutical industry, which may hinder the growth of the glycopyrronium market size and impact its growth forecast

Potential side effects and contraindications associated with glycopyrronium, which may limit its adoption and affect the overall glycopyrronium market

The glycopyrronium market presents several opportunities for growth and expansion. Two key opportunities are:

Opportunities2 items

Despite these opportunities, the glycopyrronium market also faces challenges. Two key challenges are:

Challenges2 items

Patent expirations and generic competition, which may erode the market share of branded glycopyrronium products and impact the overall glycopyrronium market size and growth forecast

Increasing pricing pressure and reimbursement constraints, which may affect the profitability of glycopyrronium manufacturers and influence the glycopyrronium market's growth trajectory

Market Segmentation

Loading chart…

glycopyrronium Segmentation Breakdown8 items

Application

Hospital

Clinic

Types

Injection

Oral Solution

Tablet

Capsule

Regional Insights

Loading chart…

Competitive Landscape

Accord Healthcare: regional expansion

AstraZeneca: innovation pipeline

Merz Pharmaceuticals: premium pricing

Carwin Pharma: local manufacturing

Sunovion Pharmaceuticals: OEM tie-ups

Shionogi Inc: vertical integration

Key glycopyrronium Companies10 items

Accord Healthcare

AstraZeneca

Merz Pharmaceuticals

Carwin Pharma

Sunovion Pharmaceuticals

Shionogi Inc

Novartis AG

Proveca Limited

Martindale Pharma

Meitheal Pharmaceuticals

Market Ecosystem

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce glycopyrronium formulations

Technology providers — develop manufacturing processes and equipment

System integrators / EPCs — integrate glycopyrronium into larger medical systems

Distributors / channel partners — supply glycopyrronium to healthcare providers

Regulators/standards bodies — oversee safety and efficacy standards

End users / buyers — prescribe and administer glycopyrronium

Recent Industry Insights

Analyst Overview

Table of Contents